ACT EU webinar on draft guidance on the conduct of clinical trials during public health emergencies

The Accelerating Clinical Trials in the EU (ACT EU) has published a draft guidance on how sponsors and other stakeholders should conduct clinical trials during public health emergencies. This webinar raises awareness of the guidance, explains the scope and recommendations, outlines how to submit comments, and addresses stakeholder questions.

• Date:
  Wednesday, 08 April 2026 , 10:00 - 11:30 Amsterdam time (CEST)
• Location:
  Online

Event summary

The Accelerating Clinical Trials in the EU (ACT EU) initiative has published a draft guidance document outlining how clinical trials should be conducted during public health emergencies (PHEs). It is open for public consultation until 30 April 2026.

The guidance is intended for sponsors and all parties involved in the design and conduct of clinical trials in the EU. This is the first guidance on PHEs to reflect the EU’s current legislative framework as well as the guidelines from the International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) developed following the COVID‑19 pandemic.

This webinar aims to:

• Raise awareness of the ongoing public consultation
• Provide an overview of the draft guidance content, including its scope and key recommendations
• Explain how the guidance aligns with the current EU legislative framework and ICH guidelines developed after COVID-19
• Clarify the consultation process, including how to submit comments using the official template
• Address questions from stakeholders regarding both the draft content and the consultation procedure

This webinar is open to members of the public, particularly relevant for patients organisations, commercial, non-commercial sponsors (including academia), health-care professionals, investigators, national competent authorities (NCAs), ethics committees, contract research organisations (CROs) and others. 

Documents

Agenda - Webinar on draft guidance on the conduct of clinical trials during public health emergencies

Registration

To participate in the webinar please register via the link below. After registration you will receive the meeting link.

• Webinar on Draft Guidance on the Conduct of Clinical Trials During Public Health Emergencies

For questions, please reach out to:

• [e-mail]

Participation via Slido

You are kindly invited to provide comments or questions on the content of draft guidance in advance via Slido (use code: #Guidance2026, or scan the QR code listed below).

You will be also able to raise questions during the Q&A sessions.

Please provide your questions by 6 April 2026, EOB.